David W. Boyer - Oct 3, 2022 Form 4 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Role: Chief Corp. Affairs Officer
Signature: /s/ Darin Lippoldt, Attorney-in-Fact
Stock symbol: NBIX
Transactions as of: Oct 3, 2022
Transactions value $: -$153,170
Form type: 4
Date filed: 10/5/2022, 07:07 PM
Previous filing: Feb 9, 2022
Next filing: Nov 2, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NBIX	Common Stock	Sale	-$153K	-1.44K	-25.43%	$106.59	4.21K	Oct 3, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Sale of 1,437 shares of common stock issued upon vesting of 2,732 restricted stock units on October 3, 2022 to cover payroll and withholding taxes, with the balance of the shares (1,295) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

Content

Sale of 1,437 shares of common stock issued upon vesting of 2,732 restricted stock units on October 3, 2022 to cover payroll and withholding taxes, with the balance of the shares (1,295) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.